ACR Congress Do Not Miss… ACR Convergence 2025: Do Not Miss – Spondyloarthritis 15 Oct 202520 Oct 2025 Piotr Kuszmiersz Piotr is a PhD in Medical Sciences and an Internal Medicine Specialist, currently undertaking his rheumatology training at the Department of Rheumatology and Immunology, Jagiellonian University Medical College…
EULAR 2025 highlights… EULAR 2025 Highlights – Spondyloarthritis: Clinical (non-therapeutic) 18 Jul 2025 Impact of Residual Disease on Disease Flares in Axial Spondyloarthritis: A Longitudinal Study in a Dutch Clinical Practice Registry Abstract format and assignment number: Oral presentation OP0097 Date: Wednesday, 11…
Spondyloarthritis I- non therapeutic EULAR 2025: Do Not Miss – Spondyloarthritis I – non-therapeutic 1 Jun 20258 Jun 2025 Olivier Fakih Olivier is a rheumatology fellow at the Department of Rheumatology of Besançon University Hospital in France. His research interests include the epidemiology of inflammatory rheumatic diseases, in particular, mortality…
ACR Highlights… ACR Convergence 2024 Highlights – Spondyloarthritis: Clinical (non-therapeutic) 19 Dec 202419 Dec 2024 Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Psoriatic Arthritis Abstract format and assignment number: Oral presentation 0772 Presenting author: A. Kerschbaumer (Austria) Date: Saturday,…
ACR Congress Do Not Miss… ACR Convergence 2024: Do Not Miss – Spondyloarthritis II – Therapeutic 5 Nov 20246 Nov 2024 Clementina López MedinaClementina is a Rheumatologist at the Reina Sofia University Hospital (Spain), a post-doctoral researcher at the Maimonides Institute of Biomedical Research of Cordoba (IMIBIC) and a Tenure Professor…
EULAR 2024 Highlights… EULAR 2024 Highlights – Spondyloarthritis I – non-therapeutic 21 Jul 202421 Jul 2024 Author: Bayram Farisogullari Da Silva et al. (POS0005) compared the spinal symptoms at baseline and after two years in early axial spondyloathritis (axSpA) patients (n = 267) and non-axSpA chronic…
Spondyloarthritis I- non therapeutic EULAR 2024: Do Not Miss – Spondyloarthritis I – non-therapeutic 8 Jun 2024 Olivier Fakih Olivier is a rheumatology fellow at the Department of Rheumatology of Besançon University Hospital in France. His research interests include the epidemiology of inflammatory rheumatic diseases, in particular mortality and comorbidities…
ACR Highlights… ACR Convergence Highlights 2023 – Spondyloarthritis I: Clinical (non-therapeutic) 9 Dec 20239 Dec 2023 Author: Olivier Fakih Michel et al. (2222) compared patients with a SpA + IBD codiagnosis versus those with only one diagnosis in a retrospective monocentric study. 62 patients with a…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Spondyloarthritis II – Therapeutic 6 Nov 2023 Diego BenaventDiego is a consultant rheumatologist at Hospital de Bellvitge, Barcelona. Aside from his activities regarding healthcare technology, his major interests are spondyloarthritis, patient-reported outcomes and musculoskeletal epidemiology. Diego the…
Spondyloarthritis… Spondyloarthritis I – Non-therapeutic 29 May 202330 May 2023 Tania Gudu Tania is a Rheumatology Consultant at Ipswich Hospital, UK where she leads the Spondyloarthritis service. Her main research interests are spondyloarthritis/ psoriatic arthritis, patient reported outcomes and MSK…